Literature DB >> 9845784

Stability of 5-aminolevulinic acid in aqueous solution.

B Elfsson1, I Wallin, S Eksborg, K Rudaeus, A M Ros, H Ehrsson.   

Abstract

The chemical stability of 5-aminolevulinic acid (ALA) was studied in aqueous solution as a function of concentration, pH, temperature and in the presence of ethylenediaminetetraacetic acid (EDTA). The degradation of ALA was followed by reversed-phase liquid chromatography using a pH where ALA is protonated (pKa1=3.90; pKa2=8. 05, as determined potentiometrically). ALA was degraded by a reaction following second order kinetics. Stock solutions of 1% (60 mM) ALA were incubated at 50 degrees C. At pH 2.35, ALA was stable during the whole incubation period (37 days). The half-lives for the second-order decomposition of 1% ALA at pH 4.81 and 7.42 were 257 and 3.0 h, respectively. The degradation rate increased about 1.5 times with each 10 degrees C rise in temperature at pH 7.53 within the range studied (37-85 degrees C). The energy of activation, Ea, for the second-order decomposition of ALA was 43.7 kJmol-1. EDTA did not influence the degradation of ALA when a mixture of 1% ALA and 1% EDTA was incubated at pH 7.42.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9845784     DOI: 10.1016/s0928-0987(98)00009-8

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  10 in total

1.  Effect of oil-in-water emulsions on 5-aminolevulinic acid uptake and metabolism to PpIX in cultured MCF-7 cells.

Authors:  Hanne Mørck Nielsen; Caroline Aemisegger; Gerd Burmeister; Ursula Schuchter; Bruno Gander
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

2.  Simple formation of an abiotic porphyrinogen in aqueous solution.

Authors:  Jonathan S Lindsey; Marcin Ptaszek; Masahiko Taniguchi
Journal:  Orig Life Evol Biosph       Date:  2009-12       Impact factor: 1.950

Review 3.  Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid.

Authors:  Noriaki Koizumi; Yoshinori Harada; Takeo Minamikawa; Hideo Tanaka; Eigo Otsuji; Tetsuro Takamatsu
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

4.  Photodynamic therapy with 5-aminolaevulinic acid and DNA damage: unravelling roles of p53 and ABCG2.

Authors:  I Postiglione; F Barra; S M Aloj; G Palumbo
Journal:  Cell Prolif       Date:  2016-07-07       Impact factor: 6.831

5.  Poly(methyl vinyl ether-alt-maleic acid) and ethyl monoester as building polymers for drug-loadable electrospun nanofibers.

Authors:  Amalia Mira; C Reyes Mateo; Ricardo Mallavia; Alberto Falco
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

6.  Biotin-Containing Third Generation Glucoheptoamidated Polyamidoamine Dendrimer for 5-Aminolevulinic Acid Delivery System.

Authors:  Aleksandra Kaczorowska; Małgorzata Malinga-Drozd; Wojciech Kałas; Marta Kopaczyńska; Stanisław Wołowiec; Katarzyna Borowska
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

7.  5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5-ALA-Mediated Anticancer Action.

Authors:  Mantas Grigalavicius; Somayeh Ezzatpanah; Athanasios Papakyriakou; Tine Therese Henriksen Raabe; Konstantina Yannakopoulou; Theodossis A Theodossiou
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

8.  Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma.

Authors:  M Otake; M Nishiwaki; Y Kobayashi; S Baba; E Kohno; T Kawasaki; Y Fujise; H Nakamura
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

9.  Derivatives of 5-aminolevulinic Acid for photodynamic therapy.

Authors:  Ryan F Donnelly; Paul A McCarron; A David Woolfson
Journal:  Perspect Medicin Chem       Date:  2007-12-11

10.  Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview.

Authors:  Angela Chiaviello; Ilaria Postiglione; Giuseppe Palumbo
Journal:  Cancers (Basel)       Date:  2011-03-03       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.